$2.74 +0.16 (%) Vivus Inc - NASDAQ

Jan. 23, 2015 | 04:00 PM

Partner Headlines

  1. Benzinga's Top #PreMarket Gainers

    Benzinga | Jan. 23, 2015 | 08:15AM EST
  2. Mid-Morning Market Update: Markets Mixed; UnitedHealth Profit Tops Expectations

    Benzinga | Jan. 21, 2015 | 10:42AM EST
  3. 5 Obesity Stocks Investors Are Watching

    Benzinga | Jan. 14, 2015 | 13:55PM EST
  4. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 4

    Benzinga | Jan. 13, 2015 | 11:34AM EST
  5. Stocks Hitting 52-Week Lows

    Benzinga | Dec. 30, 2014 | 10:31AM EST
  6. 4 Potential Blockbuster Drugs The FDA Just Approved

    IBD | Dec. 26, 2014 | 12:35PM EST
  7. Orexigen Therapeutics Gains On Diet Pill Nod From European Committee

    Benzinga | Dec. 19, 2014 | 14:09PM EST
  8. Pharmaceutical Stocks In Play Following Merck/Cubist Deal

    Benzinga | Dec. 8, 2014 | 09:09AM EST
  9. What's Driving Orexigen Therapeutics Higher?

    Benzinga | Nov. 13, 2014 | 12:10PM EST
  10. Earnings Scheduled For November 5, 2014

    Benzinga | Nov. 5, 2014 | 05:05AM EST
  11. 3 Pharma Companies Fighting Obesity

    Benzinga | Oct. 30, 2014 | 14:00PM EST
  12. Bank Of America Q3 Small & Mid-Cap Biotech Preview

    Benzinga | Oct. 20, 2014 | 16:58PM EST
  13. Endo Buyout Of Auxilium Joins Two Changing Firms

    IBD | Oct. 9, 2014 | 19:00PM EST
  14. Vivus, Inc. Opens Sharply Higher On ED Drug Marketing Approval

    Benzinga | Sep. 18, 2014 | 09:55AM EST
  15. Morning Market Movers

    Benzinga | Sep. 18, 2014 | 09:46AM EST
  16. Benzinga's Top #PreMarket Gainers

    Benzinga | Sep. 18, 2014 | 08:05AM EST
  17. US Stock Futures Up Ahead Of Jobless Claims, Housing Starts Data

    Benzinga | Sep. 18, 2014 | 07:10AM EST
  18. FDA delays Orexigen drug

    IBD | Jun. 11, 2014 | 18:57PM EST
  19. Orexigen Obesity Drug Decision Delayed By FDA

    IBD | Jun. 11, 2014 | 11:55AM EST
  20. Orexigen Shares Plummet Following FDA Decision; Competition Gets A Bump

    Benzinga | Jun. 11, 2014 | 11:24AM EST
  21. Is Vivus About To Get Squeezed?

    Benzinga | Jun. 9, 2014 | 14:54PM EST
  22. Benzinga's Top #PreMarket Gainers

    Benzinga | May. 6, 2014 | 08:06AM EST
  23. Shares of Vivus Fall +10% Following Piper Jaffray's Downgrade

    Benzinga | Apr. 3, 2014 | 13:03PM EST
  24. Mid-Day Market Update: US Stocks Fall; Google Shares Rise After Stock Split

    Benzinga | Apr. 3, 2014 | 12:41PM EST
  25. Mid-Morning Market Update: Markets Mostly Flat; Greenbrier Results Beat Estimates

    Benzinga | Apr. 3, 2014 | 10:43AM EST
  26. Morning Market Losers

    Benzinga | Apr. 3, 2014 | 09:49AM EST
  27. Benzinga's Top #PreMarket Losers

    Benzinga | Apr. 3, 2014 | 08:29AM EST
  28. Benzinga's Top Downgrades

    Benzinga | Apr. 3, 2014 | 07:47AM EST
  29. Biotech Auxilium Boosts Position In Men's Health Care

    IBD | Apr. 1, 2014 | 17:31PM EST
  30. Weekly Three-Year Low Highlight: VVUS, RALY, WILN, COVS

    GuruFocus | Mar. 25, 2014 | 11:50AM EST
  31. Vivus Announces Review Article Summarizing Cardiovascular Benefit-Risk Profile of Qsymia

    Benzinga | Mar. 25, 2014 | 07:50AM EST
  32. Auxilium Q4 Beats Estimates, But Guidance Cautious

    IBD | Feb. 28, 2014 | 10:42AM EST
  33. Mid-Afternoon Market Update: Markets Turn Red as Tesla Continues to Rip Higher

    Benzinga | Feb. 25, 2014 | 15:51PM EST
  34. Mid-Day Market Update: US Stocks Mostly Flat; Office Depot Shares Decline On Q4 Results

    Benzinga | Feb. 25, 2014 | 13:07PM EST
  35. Mid-Morning Market Update: Markets Fall; Home Depot Profit Beats Estimates

    Benzinga | Feb. 25, 2014 | 11:44AM EST
  36. UPDATE: Vivus Down Nearly 12% After JP Morgan Downgrade on Lackluster Qsymia News

    Benzinga | Feb. 25, 2014 | 11:30AM EST
  37. Stocks Hitting 52-Week Lows

    Benzinga | Feb. 25, 2014 | 10:21AM EST
  38. Morning Movers for Feb. 25, 2014: IMUC, MSO, ZU, CARA, VSI, TSLA, XOMA, BCRX Moving Higher, RP, ODP, VVUS, AINV, MGIC, ALSN Lower

    Benzinga | Feb. 25, 2014 | 09:41AM EST
  39. Benzinga's Top #PreMarket Losers

    Benzinga | Feb. 25, 2014 | 08:14AM EST
  40. UPDATE: Bank of America Downgrades Vivus as Partnering Prospects Weaken

    Benzinga | Feb. 25, 2014 | 08:12AM EST
  41. US Stock Futures Slip Ahead Of Economic Data

    Benzinga | Feb. 25, 2014 | 07:22AM EST
  42. Benzinga's Top #PreMarket Gainers

    Benzinga | Jan. 14, 2014 | 08:09AM EST
  43. The Top Five Drug Launches Of 2013

    IBD | Dec. 31, 2013 | 13:42PM EST
  44. New ED Drug: Analysis of Vivus’s Prospects

    YCharts | Dec. 23, 2013 | 14:09PM EST
  45. VIVUS Announces License and Commercialization Agreement With Sanofi for Avanafil in Africa, Middle East, Turkey and CIS/Russia

    Benzinga | Dec. 12, 2013 | 07:01AM EST
  46. VIVUS Awarded Two US Patents for Qsymia; Patent Coverage for Qsymia Extended to 2029

    Benzinga | Nov. 13, 2013 | 07:03AM EST
  47. Stocks Hitting 52-Week Lows

    Benzinga | Nov. 6, 2013 | 10:20AM EST
  48. UPDATE: Bank of America Downgrades Vivus on Weaker Partnering Prospects

    Benzinga | Nov. 6, 2013 | 09:09AM EST
  49. Benzinga's Top Downgrades

    Benzinga | Nov. 6, 2013 | 07:57AM EST
  50. US Stock Futures Up Ahead Of Time Warner Earnings

    Benzinga | Nov. 6, 2013 | 07:08AM EST
Trading Center